Dr. Ponce Martinez highlights the need to identify and manage alcohol withdrawal in psychiatric settings, underscoring the use of the CIWA-Ar scale for monitoring symptom progression. While benzodiazepines remain the primary treatment, she reviews alternative treatment strategies and tells us which patients are so high risk that they must be transferred to a medical unit for care.

Substance-induced psychosis (SIP) presents diagnostic challenges in distinguishing it from primary psychotic disorders, with substance timing, symptom type, and duration being key differentiators. Effective treatment combines antipsychotic medications and substance cessation strategies. Dr. Athanasiou reviews key points in the management of SIP.

By successfully completing the test you will be awarded a certificate for 2 CME credit.

After reading these articles, you should be able to...

By initiating LAIs early in the course of a patient’s illness, we can significantly delay the time to first hospitalization in young adults. 

This large study gives us reassuring data about neurodevelopmental outcomes in children exposed to several second-generation antipsychotic medications during pregnancy.

Postpartum depression is surprisingly common, yet often missed. We discuss screening techniques to ensure you won’t miss it, and share treatment approaches, including novel strategies like brexanolone, zuranolone, and TMS.

You might worry about prescribing antidepressants during pregnancy, but data on their safety is increasingly reassuring. We provide an in-depth review on how to treat depression in pregnancy and breastfeeding.

The management of bipolar disorder during pregnancy can be tricky. Some medications can be harmful to the fetus, and others need to be adjusted carefully due to changes in kidney and liver function. We walk you through the important considerations to keep in mind when working with these patients.